-
1
المؤلفون: Koichi Seta, Kazutaka Nanba, Akihiro Yasoda, Naoki Esaka, Kohei Fujita, Hiroaki Hata, Osamu Kanai, Takao Odagaki, Tadashi Mio
المصدر: Drugs & Aging
مصطلحات موضوعية: medicine.medical_specialty, Alanine, Coronavirus disease 2019 (COVID-19), Exacerbation, SARS-CoV-2, business.industry, Incidence (epidemiology), Antiviral Agents, Adenosine Monophosphate, COVID-19 Drug Treatment, Discontinuation, Older patients, Internal medicine, medicine, Humans, Pharmacology (medical), Original Research Article, Geriatrics and Gerontology, Liver dysfunction, Patient group, Adverse effect, business, Aged, Retrospective Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2e8d3c6379cedfc3417dd197fc8b32cTest
https://doi.org/10.1007/s40266-021-00908-9Test -
2
المؤلفون: Misato Okamura, Tadashi Mio, Zentaro Saito, Koichi Nakatani, Kohei Fujita, Yuki Yamamoto, Osamu Kanai, Takanori Ito, Satoru Sawai, Masayuki Hashimoto
المصدر: Cancer Reports
Cancer Reports, Vol 4, Iss 6, Pp n/a-n/a (2021)مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Population, Pembrolizumab, elderly patients, Atezolizumab, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, education, Lung cancer, Adverse effect, Immune Checkpoint Inhibitors, immune checkpoint, RC254-282, Retrospective Studies, Aged, 80 and over, education.field_of_study, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Original Articles, medicine.disease, Prognosis, Survival Rate, Pneumonia, lung cancer, Oncology, Female, Original Article, immunotherapy, Nivolumab, business, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fd474532d6af89f5f94c082dcfd9c9dTest
https://pubmed.ncbi.nlm.nih.gov/33934572Test -
3
المؤلفون: Osamu Kanai, Naohiro Uchida, Kohei Fujita, Tadashi Mio, Koichi Nakatani, Misato Okamura, Satoru Sawai, Yuki Yamamoto
المصدر: Anticancer Research. 39:3917-3921
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Programmed Cell Death 1 Receptor, Antineoplastic Agents, Pembrolizumab, Antibodies, Monoclonal, Humanized, Gastroenterology, Atezolizumab, Carcinoma, Non-Small-Cell Lung, Internal medicine, Humans, Medicine, Lung cancer, Adverse effect, Aged, Retrospective Studies, biology, business.industry, Antibodies, Monoclonal, General Medicine, Middle Aged, medicine.disease, Nivolumab, Treatment Outcome, Oncology, Retreatment, biology.protein, Female, Non small cell, Antibody, business, Progressive disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f1cb27383fd9b825a9e9ff55aa6181aTest
https://doi.org/10.21873/anticanres.13543Test -
4
المؤلفون: Mitsuteru Koizumi, Koki Moriyoshi, Seijiro Tsuji, Tadashi Mio, Naohiro Uchida, Kohei Fujita
المصدر: Clinical Case Reports
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Immune checkpoint inhibitors, medicine.medical_treatment, Latent phase, 030232 urology & nephrology, Case Report, Case Reports, 030204 cardiovascular system & hematology, urologic and male genital diseases, immune checkpoint inhibitors, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Adverse effect, Lung cancer, nivolumab, business.industry, Acute kidney injury, General Medicine, Immunotherapy, medicine.disease, female genital diseases and pregnancy complications, acute kidney injury, Non small cell, Nivolumab, business, immune‐related adverse event
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6702a3be46b00e36f1e021c10c67a36bTest
https://doi.org/10.1002/ccr3.1848Test -
5
المؤلفون: Yuki Yamamoto, Kohei Fujita, Tadashi Mio, Koichi Nakatani, Misato Okamura, Osamu Kanai
المصدر: Tuberculosis.
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Tuberculosis, business.industry, medicine.medical_treatment, Incidence (epidemiology), Immune checkpoint inhibitors, Immunotherapy, medicine.disease, Clinical trial, Cancer immunotherapy, Internal medicine, medicine, Interferon gamma, business, Adverse effect, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1f2cfa345a36d748bed887a646abcaa9Test
https://doi.org/10.1183/13993003.congress-2020.5298Test -
6
المؤلفون: Kohei Fujita, Koichi Nakatani, Tadashi Mio, Masayuki Hashimoto, Satoru Sawai, Misato Okamura, Kanna Horimoto, Osamu Kanai, Keiko Takeda
المصدر: Lung cancer.
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Retrospective cohort study, Odds ratio, medicine.disease, Comorbidity, Gastroenterology, Confidence interval, Internal medicine, Medicine, Progression-free survival, Nivolumab, business, Lung cancer, Adverse effect
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1ca1bf488084c93d496ac0338a820628Test
https://doi.org/10.1183/13993003.congress-2019.pa368Test -
7
المؤلفون: Satoru Sawai, Yuki Yamamoto, Osamu Kanai, Masayuki Hashimoto, Misato Okamura, Kohei Fujita, Koichi Nakatani, Tadashi Mio
المصدر: Thoracic Cancer
Thoracic Cancer, Vol 11, Iss 1, Pp 15-18 (2020)مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Male, medicine.medical_specialty, Durvalumab, Lung Neoplasms, Programmed Cell Death 1 Receptor, Gastroenterology, lcsh:RC254-282, B7-H1 Antigen, immune checkpoint inhibitors, 03 medical and health sciences, anti‐PD‐L1, 0302 clinical medicine, Antineoplastic Agents, Immunological, Atezolizumab, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Biomarkers, Tumor, Humans, Adverse effect, Lung cancer, Aged, Retrospective Studies, Salvage Therapy, biology, business.industry, Anti pd 1, General Medicine, Original Articles, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, Survival Rate, lung cancer, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Anti‐PD‐1, Retreatment, biology.protein, Female, Original Article, Non small cell, Antibody, business, Progressive disease, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8412329c746af54fe5676fa8755641b2Test
https://pubmed.ncbi.nlm.nih.gov/31701630Test -
8
المؤلفون: Mitsunori Morita, Takehiro Yasuda, Satoshi Hara, Naoki Sakai, Keisuke Tomii, Motonari Fukui, Yasushi Fukuda, Toyohiro Hirai, Masataka Hirabayashi, Manabu Ishitoko, Tadashi Ishida, Moon Hee Hwang, Hitoshi Nakaji, Takakazu Sugita, Yuki Kataoka, Hiroshige Yoshioka, Takeshi Morimoto, Tadashi Mio, Daichi Fujimoto, Young Hak Kim
المصدر: Lung Cancer. 119:14-20
مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Multivariate analysis, Drug-Related Side Effects and Adverse Reactions, Cohort Studies, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Adverse effect, Lung cancer, Aged, Retrospective Studies, Pneumonitis, business.industry, Retrospective cohort study, Pneumonia, Middle Aged, medicine.disease, Survival Analysis, ErbB Receptors, Clinical trial, Nivolumab, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, Observational study, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215d5b4a649eab1ea4777853e65d9af8Test
https://doi.org/10.1016/j.lungcan.2018.02.017Test -
9
المؤلفون: Misato Okamura, Koichi Nakatani, Kohei Fujita, Osamu Kanai, Naohiro Uchida, Tadashi Mio
المصدر: Cancer Chemotherapy and Pharmacology. 81:1105-1109
مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, Antibodies, Monoclonal, Humanized, Toxicology, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Pharmacology (medical), In patient, Lung cancer, Adverse effect, Aged, Retrospective Studies, Pharmacology, Chemotherapy, business.industry, Middle Aged, medicine.disease, Nivolumab, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Retreatment, Female, Non small cell, Previously treated, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606e52f7e1d44d539d458751a71bed19Test
https://doi.org/10.1007/s00280-018-3585-9Test -
10
المؤلفون: Kohei Fujita, Naohiro Uchida, Koichi Nakatani, Tadashi Mio, Misato Okamura
المصدر: Respiratory Medicine Case Reports, Vol 26, Iss, Pp 39-41 (2019)
Respiratory Medicine Case Reportsمصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, Case Report, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Carcinoma, Adverse effect, Thymic carcinoma, lcsh:RC705-779, Chemotherapy, biology, business.industry, lcsh:Diseases of the respiratory system, medicine.disease, Clinical trial, 030228 respiratory system, 030220 oncology & carcinogenesis, biology.protein, Histopathology, Nivolumab, Antibody, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::036fa06a5e04153308015d4dad84149fTest
http://www.sciencedirect.com/science/article/pii/S2213007118300650Test